Incyte Corporation Share Price Today: Live Updates & Key Insights
Incyte Corporation share price today is $91.72, up -2.33%. The stock opened at $92.81 against the previous close of $92.95, with an intraday high of $93.34 and low of $90.34.
Incyte Corporation Share Price Chart
Incyte Corporation
Incyte Corporation Share Price Performance
Incyte Corporation Institutional Holdings
Incyte Corporation Market Status
Incyte Corporation Fundamentals
Market Cap 18066.53 M
PB Ratio 3.4962
PE Ratio 14.1622
Enterprise Value 14526.34 M
Total Assets 6957.97 M
Volume 4388758
Incyte Corporation Company Financials
About Incyte Corporation & investment objective
Company Information Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for the treatment of chronic graft-versus-host disease. It also provides INCA033989 for the treatment of essential thrombocythemia and MF; INCA035784 for the treatment of anti-mutant calreticulin and myeloproliferative neoplasms (MPNs); INCB160058 for the treatment of MPNs; PEMAZYRE, a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ZYNYZ to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma. The company's clinical stage products include INCB123667 for ovarian cancer; INCB161734 for solid tumors; INCA33890 for cancers; Ruxolitinib cream for atopic dermatitis, hidradenitis suppurativa (HS), and prurigo nodularis; Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma; and INCB00928 for the treatment of fibrodysplasia ossificans progressive. It has collaboration and license agreement with Novartis, Lilly, and Syndax. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and distributors. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Organisation Biotechnology
Employees 2844
Industry Biotechnology
CEO Mr. William J. Meury
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Incyte Corporation FAQs
What is the share price of Incyte Corporation today?
The current share price of Incyte Corporation is $91.72.
Can I buy Incyte Corporation shares in India?
Yes, Indian investors can buy Incyte Corporation shares by opening an international trading and demat account with Motilal Oswal.
How to buy Incyte Corporation shares in India?
You can easily invest in Incyte Corporation shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Incyte Corporation shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Incyte Corporation.
Can I buy fractional shares of Incyte Corporation?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Incyte Corporation?
Incyte Corporation has a market cap of $18066.53 M.
In which sector does Incyte Corporation belong?
Incyte Corporation operates in the Biotechnology sector.
What documents are required to invest in Incyte Corporation stocks?
To invest, you typically need:
What is the PE and PB ratio of Incyte Corporation?
The PE ratio of Incyte Corporation is 14.16 and the PB ratio is 3.50.